Millipore Receives Virus Filtration Patents
Patented processes increase capacity and robustness of virus clearanceUS Patent 7,118,675 B2 covers the use of adsorptive depth filters or charged or surface-modified microfiltration membranes in front of a viral filter to enhance the virus filter performance by removing aggregates from protein solutions.
US Patent 7,465,397B2 involves the process of removing aggregates and viruses using a depth filter upstream of a viral filter in either a constant pressure or pump system. Adsorptive depth filters and modified microfiltration filters that allow for increased capacity and robustness of Millipore virus filters are part of Millipore’s Viresolve® offering.
About Millipore
Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 5,900 employees in 30 countries worldwide. For more information, visit www.millipore.com.
ADVANCING LIFE SCIENCE TOGETHERTM
Research. Development. Production.
Millipore Media Contact:
Shannon Meirzon
Bioprocess Communications
Millipore Corporation
781.533.2706
shannon_meirzon@millipore.com
Press Contact:
Alexandra Paparsenos
Gray & Rice Public Relations
(617) 367.0100 x 155
apaparsenos@gr2000.com
Millipore and Viresolve are registered trademarks; and the “M” logo and ADVANCING LIFE SCIENCE TOGETHER are trademarks of Millipore Corporation.
Find A Location
Find the Millipore office or expert closest to you.
Contact Us
We want to hear from you. Contact a specific department below or click "Suggestions and Feedback" to send your comments.

